Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Feb 3, 2010 roberts william Officer Option Execute 1,500 13.00
Dec 15, 2014 mccorkle douglas s Officer Option Execute 1,668 30.63
Dec 15, 2014 mccorkle douglas s Officer Automatic Sell 1,668 410.16 - 417.34
Aug 27, 2014 mccorkle douglas s Officer Option Execute 1,681 21.25 - 30.63
Mar 30, 2011 brown michael s Director Automatic Sell 1,691 44.35
Mar 17, 2011 gilman alfred g Director Sell 1,700 38.97
Dec 15, 2008 goldberg murray a Officer Option Execute 1,700 7.41
Oct 7, 2010 brown michael s Director Automatic Sell 1,765 28.03
Dec 19, 2012 mccorkle douglas s Officer Automatic Sell 1,841 174.52 - 180.75
Dec 17, 2012 goldberg murray a Officer Option Execute 1,850 20.32
Mar 30, 2012 vagelos p roy Officer Disposition (Non Open Market) 1,852 n/a
Jul 12, 2012 vagelos p roy Officer Disposition (Non Open Market) 1,860 n/a
Oct 25, 2012 brown michael s Director Sell 2,000 155.34
Mar 17, 2014 brown michael s Director Automatic Sell 2,000 333.42 - 336.49
Mar 17, 2014 brown michael s Director Option Execute 2,000 33.42
Oct 25, 2012 brown michael s Director Option Execute 2,000 23.84
Dec 12, 2007 gilman alfred g Director Disposition (Non Open Market) 2,000 n/a
Nov 17, 2009 gilman alfred g Director Disposition (Non Open Market) 2,000 n/a
Jan 2, 2009 gilman alfred g Director Acquisition (Non Open Market) 2,000 n/a
Jan 2, 2009 gilman alfred g Director Disposition (Non Open Market) 2,000 n/a
Showing 61-80 of 873 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)